Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (141-150 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|April 25, 2015
Loss of Wave1 gene defines a subtype of lethal prostate cancerAdam G Sowalsky, Rebecca Sager, Rachel J Schaefer, et al.
Oncotarget|April 28, 2015
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axisSong Fan, Bodu Liu, Lijuan Sun, et al.
Oncotarget|April 29, 2015
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trialEric Assenat, David Azria, Caroline Mollevi, et al.
Oncotarget|April 29, 2015
Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor modelRamaswamy Bhuvaneswari, Qin Feng Ng, Patricia S P Thong, et al.
Oncotarget|April 20, 2015
Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolismSandra Leisz, Kristin Schulz, Susanne Erb, et al.
Oncotarget|April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLCFrancesco Morra, Chiara Luise, Francesco Merolla, et al.
Oncotarget|April 19, 2015
MET receptor is a potential therapeutic target in high grade cervical cancerKatarzyna Miekus, Marta Pawlowska, Małgorzata Sekuła, et al.
Oncotarget|April 19, 2015
RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activationSusanne V Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, et al.
Oncotarget|April 19, 2015
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancerAnm Nazmul H Khan, Nonna Kolomeyevskaya, Kelly L Singel, et al.
Oncotarget|April 21, 2015
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinomaXiufeng Jiang, Kang Feng, Ye Zhang, et al.
Pageof 2,673

Showing results (141-150 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|April 25, 2015
Loss of Wave1 gene defines a subtype of lethal prostate cancerAdam G Sowalsky, Rebecca Sager, Rachel J Schaefer, et al.
Oncotarget|April 28, 2015
Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axisSong Fan, Bodu Liu, Lijuan Sun, et al.
Oncotarget|April 29, 2015
Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trialEric Assenat, David Azria, Caroline Mollevi, et al.
Oncotarget|April 29, 2015
Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor modelRamaswamy Bhuvaneswari, Qin Feng Ng, Patricia S P Thong, et al.
Oncotarget|April 20, 2015
Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolismSandra Leisz, Kristin Schulz, Susanne Erb, et al.
Oncotarget|April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLCFrancesco Morra, Chiara Luise, Francesco Merolla, et al.
Oncotarget|April 19, 2015
MET receptor is a potential therapeutic target in high grade cervical cancerKatarzyna Miekus, Marta Pawlowska, Małgorzata Sekuła, et al.
Oncotarget|April 19, 2015
RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activationSusanne V Schmidt, Stefanie Seibert, Barbara Walch-Rückheim, et al.
Oncotarget|April 19, 2015
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancerAnm Nazmul H Khan, Nonna Kolomeyevskaya, Kelly L Singel, et al.
Oncotarget|April 21, 2015
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinomaXiufeng Jiang, Kang Feng, Ye Zhang, et al.
Pageof 2,673